Since incretin hormones are rapidly degraded by DPP4, it is reasonable to assume that an increase in DPP4 level and/or enzymatic activity may contribute to the impaired incretin effect observed in patients with T2DM [12]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.